EAM Investors’s Viemed Healthcare VMD Stock Holding History

EAM Investors’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Buy	+109,592	New	+$1.09M	0.11%	211
2023 Q3	–	Sell	-108,371	Closed	-$1.06M	–	386
2023 Q2	$1.06M	Sell	108,371 -139,632	-56%	-$1.42M	0.2%	235
2023 Q1	$2.4M	Buy	248,003 +136,972	+123%	+$1.19M	0.47%	73
2022 Q4	$842K	Hold	111,031	–	–	0.17%	241
2022 Q3	$671K	Buy	+111,031	New	+$713K	0.15%	243
2019 Q4	–	Sell	-105,951	Closed	-$731K	–	321
2019 Q3	$731K	Buy	+105,951	New	+$706K	0.19%	206

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

EAM Investors's VMD Position: Q2 2026 in Review

EAM Investors opened a new position in Viemed Healthcare (VMD) in Q2 2026: 109,592 shares worth $1.25M. The stake represents 0.11% of the portfolio and ranks #211 among its holdings. This is a return to the name: EAM Investors previously reported a position in VMD as recently as Q2 2023.

EAM Investors first reported a position in VMD in Q3 2019 and has held it in 6 quarters since. The position peaked at $2.4M in Q1 2023. 167 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

EAM Investors held 109,592 shares of Viemed Healthcare worth $1.25M as of Q2 2026.
Viemed Healthcare was a new EAM Investors position in Q2 2026.
Viemed Healthcare made up 0.11% of EAM Investors's portfolio in Q2 2026, its #211 holding.
EAM Investors first reported a position in Viemed Healthcare in Q3 2019 and has held it in 6 quarters since.
EAM Investors's Viemed Healthcare position peaked at $2.4M in Q1 2023.
167 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.